NCT05183932

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

Comparing the Effectiveness of Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (SORT)

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 446 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be consented after their treatment plan has been determined. Prospectively collected patient-reported outcomes (PROs) will be collected for 3 years or for the duration of the study (whichever is shorter), as will outcomes data.

Conditions

• Non Small Cell Lung Cancer
• Non-small Cell Lung Cancer

Timeline

• Start date: 2022-07-14
• Primary completion: 2029-01-31
• Completion: 2029-01-31
• First posted: 2022-01-11
• Last updated: 2026-04-07

Locations

8 sites across 2 countries: United States, Canada